NIVF (NIVF) Stock Price & Analysis
NIVF (NIVF) fell 9.84% to USD 1.1 as of July 25, 2026 at 03:40 UTC, according to Nexqual real-time market data.
NIVF last closed at USD 1.22; the session ranged USD 1.1–1.24 on volume of 172,793 shares. Market capitalization is $3.76M, with a 52-week range of USD 1.1–568.8 (NCM). Source: Nexqual, July 25, 2026 at 03:40 UTC.
Key Statistics (as of July 25, 2026 at 03:40 UTC)
| Price | USD 1.1 |
|---|---|
| Change | ▼ 9.84% (down) |
| Previous Close | USD 1.22 |
| Open | USD 1.19 |
| Day Range | USD 1.1 – 1.24 |
| 52-Week Range | USD 1.1 – 568.8 |
| Volume | 172,793 shares |
| Market Cap | $3.76M |
| Exchange | NCM |
Technical Analysis (NIVF)
Nexqual's technical model rates NIVF "SELL" based on 1 bullish and 5 bearish signals across 125 daily candles, as of July 25, 2026 at 03:40 UTC.
| Overall Signal | SELL |
|---|---|
| RSI (14) | 32.53 (neutral) |
| vs SMA50 | Below (USD 1.95) |
| MACD | -0.26 (negative) |
Analyst Ratings (NIVF)
Wall Street analysts rate NIVF "None" based on 1 analysts, with a mean price target of USD 42.36 (range USD 42.36–42.36), per Nexqual as of July 25, 2026 at 03:40 UTC.
| Consensus Rating | None |
|---|---|
| Analyst Count | 1 |
| Mean Target | USD 42.36 |
| High Target | USD 42.36 |
| Low Target | USD 42.36 |
| Buy / Hold / Sell | 0 / 0 / 0 |
Earnings (NIVF)
Source: Nexqual, July 25, 2026 at 03:40 UTC.
Financials & Fundamentals (NIVF)
| Total Revenue | $4.73M |
|---|---|
| Revenue Growth (YoY) | +11.90% |
| Gross Margin | +20.22% |
| Operating Margin | -349.13% |
| Profit Margin | +209.03% |
| ROE | +79.40% |
| Debt / Equity | 18.74 |
| Current Ratio | 3.12 |
| Total Cash | $958,556 |
| Total Debt | $4.87M |
| Free Cash Flow | $-10.46M |
Source: Nexqual, July 25, 2026 at 03:40 UTC.
Financial Health Score (NIVF)
Nexqual rates NIVF's overall financial health "Mixed" across five dimensions, as of July 25, 2026 at 03:40 UTC.
| Growth | Solid — Revenue +12% YoY (latest Q) |
|---|---|
| Profitability | Critical — Heavily loss-making — early-stage company |
| Balance Sheet | Strong — $959K cash vs $5M debt |
| Cash Flow | Weak — FCF negative: -$10M, burning cash |
| Efficiency | Strong — ROE 79%, ROA -36.9% |
Ownership (NIVF)
| Insider Ownership | +0.00% |
|---|---|
| Institutional Ownership | +0.51% |
| Shares Outstanding | 3.42M |
| Float | 187,374 |
| Short % of Float | +6.50% |
Source: Nexqual, July 25, 2026 at 03:40 UTC.
Leadership (NIVF)
NIVF is led by Wing Fung Siu (age 69), Co-Founder, Chairman & CEO, per Nexqual as of July 25, 2026 at 03:40 UTC.
| Co-Founder, Chairman & CEO | Wing Fung Siu (age 69) |
|---|---|
| Co-Founder, Chief Marketing Officer & Director | Hei Yue Fong (age 43) |
| Chief Financial Officer | Ho Fai Chung (age 61) |
Peers & Related Stocks
| Symbol | Name | Price | Change |
|---|---|---|---|
| TWG | Top Wealth Group Holding Limite | USD 2.48 | ▼ 2.82% |
| MNDR | Mobile-health Network Solutions | USD 2.18 | ▼ 24.57% |
| LRHC | La Rosa Holdings Corp. | USD 0.97 | ▲ 5.87% |
| BDRX | Biodexa Pharmaceuticals plc | USD 1.65 | ▼ 3.51% |
| ATPC | Agape ATP Corporation | USD 2.46 | ▼ 2.77% |
Data source: Nexqual — real-time market data, technical indicators, analyst consensus, earnings, SEC EDGAR filings. Last updated: July 25, 2026 at 03:40 UTC. This page is informational and not investment advice.